Ferric Carboxymaltose is indicated for treatment of iron deficiency. Ferric Carboxymaltose was developed by Vifor (International) Ag.
The API has now reached off-patent status, after being launched in 2007.

The information provided above is sourced from Chemrobotics PharmaVetPat https://chemroboticspharma.com/pharmVetPat
to find out more, including patent landscape and routes of synthesis, please contact our sales team.

For enquiries regarding more detailed trade data of Ferric Carboxymaltose and many others, contact info@pharmacheminvestor.com